Neuromodulation trials

Effect of Neuromodulation on Pain Biomarkers and Functional Outcome in Patients With Fibromyalgia Syndrome

RecruitingNCT06539793Phase: NAStarted 2024-09-01

Summary

Fibromyalgia is the third most common musculoskeletal condition in terms of prevalence, after lumbar pain and osteoarthritis. Its prevalence is around 2-4 % and is more frequent in women than in men;

Eligibility

Sex
ALL
Min Age
25 Years
Max Age
35 Years

Locations

Al Ryada University for Science and TechnologySadat, Menoufia, Egypt

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT06539793